Evaluation of Neuromuscular Diseases and Complaints by Quantitative Muscle MRI

Lara Schlaffke,Robert Rehmann,Anne-Katrin Güttsches,Matthias Vorgerd,Christine H. Meyer-Frießem,Hubert R. Dinse,Elena Enax-Krumova,Martijn Froeling,Johannes Forsting

DOI: https://doi.org/10.3390/jcm13071958

IF: 3.9

2024-03-29

Journal of Clinical Medicine

Abstract:Background: Quantitative muscle MRI (qMRI) is a promising tool for evaluating and monitoring neuromuscular disorders (NMD). However, the application of different imaging protocols and processing pipelines restricts comparison between patient cohorts and disorders. In this qMRI study, we aim to compare dystrophic (limb-girdle muscular dystrophy), inflammatory (inclusion body myositis), and metabolic myopathy (Pompe disease) as well as patients with post-COVID-19 conditions suffering from myalgia to healthy controls. Methods: Ten subjects of each group underwent a 3T lower extremity muscle MRI, including a multi-echo, gradient-echo, Dixon-based sequence, a multi-echo, spin-echo (MESE) T2 mapping sequence, and a spin-echo EPI diffusion-weighted sequence. Furthermore, the following clinical assessments were performed: Quick Motor Function Measure, patient questionnaires for daily life activities, and 6-min walking distance. Results: Different involvement patterns of conspicuous qMRI parameters for different NMDs were observed. qMRI metrics correlated significantly with clinical assessments. Conclusions: qMRI metrics are suitable for evaluating patients with NMD since they show differences in muscular involvement in different NMDs and correlate with clinical assessments. Still, standardisation of acquisition and processing is needed for broad clinical use.

medicine, general & internal

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate and monitor the muscle conditions of patients with neuromuscular diseases (NMD), especially limb - girdle muscular dystrophy (LGMD), inclusion body myositis (IBM), Pompe disease and post - COVID - 19 condition patients (PCC) through quantitative muscle magnetic resonance imaging (qMRI), and compare them with the healthy control group. The main objectives of the study are:

1. **Evaluate the muscle involvement patterns in different NMD patients**: By using multiple qMRI techniques, such as Dixon - based sequences, multi - echo spin - echo (MESE) T2 mapping sequences and spin - echo EPI diffusion - weighted sequences, to identify the change patterns of parameters such as muscle fat fraction (FF), water T2 relaxation time (T2), fractional anisotropy (FA) and mean diffusivity (MD) in different NMD patients.

2. **Explore the correlation between qMRI parameters and clinical assessment**: Analyze the relationship between qMRI parameters (such as FF, T2, FA, MD) and clinical assessment indicators (such as 6 - minute walk distance (6 - MWD), Quick Motor Function Measurement (QMFM), etc.) to verify the value of qMRI in clinical applications.

3. **Standardize the acquisition and processing of qMRI**: Propose standardized qMRI acquisition and data processing methods for effective comparison between different research sites and disease types, thereby promoting the wide application of qMRI in clinical practice.

Through these goals, the study aims to demonstrate the potential of qMRI as a non - invasive and objective tool in evaluating and monitoring neuromuscular diseases, especially its application in capturing disease - specific muscle involvement patterns and correlation with clinical outcomes. In addition, the study also emphasizes the importance of standardized qMRI acquisition and processing methods, which are crucial for the wide adoption of qMRI in clinical practice.